继发性抗体缺陷患者的新型冠状病毒肺炎相关机化性肺炎对免疫球蛋白有反应。
COVID-19-related organising pneumonia in patients with secondary antibody deficiency responds to immunoglobulin.
作者信息
Moolji Jalal, Leung Winnie M, Richman-Eisenstat Janice, Adatia Adil
机构信息
Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Alberta Respiratory Centre, Edmonton, AB, Canada.
出版信息
ERJ Open Res. 2025 May 12;11(3). doi: 10.1183/23120541.00660-2024. eCollection 2025 May.
Abstract
摘要
https://bit.ly/3Yy2wlE. （此为网址，无法完全准确翻译为中文，保留原文形式）
相似文献
1
COVID-19-related organising pneumonia in patients with secondary antibody deficiency responds to immunoglobulin.继发性抗体缺陷患者的新型冠状病毒肺炎相关机化性肺炎对免疫球蛋白有反应。
ERJ Open Res. 2025 May 12;11(3). doi: 10.1183/23120541.00660-2024. eCollection 2025 May.
2
Secondary Organising Pneumonia Caused by Denosumab.地诺单抗引起的继发性机化性肺炎。
Eur J Case Rep Intern Med. 2023 Sep 15;10(10):004043. doi: 10.12890/2023_004043. eCollection 2023.
3
Computed tomography after severe COVID-19 pneumonia: findings at 6 months and beyond.重症新型冠状病毒肺炎后的计算机断层扫描：6个月及以后的表现
ERJ Open Res. 2021 Oct 25;7(4). doi: 10.1183/23120541.00488-2021. eCollection 2021 Oct.
4
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.新冠康复者血浆或超免疫球蛋白用于新冠患者：快速综述
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
5
Acute fibrinous and organising pneumonia: a case report and review of the literature.急性纤维素性机化性肺炎：一例病例报告及文献综述
J Med Case Rep. 2009 Oct 12;3:74. doi: 10.1186/1752-1947-3-74.
6
Secondary Organising Pneumonia Among COVID-19 Patients: A Retrospective Case-Control Study.新型冠状病毒肺炎患者中的继发性机化性肺炎：一项回顾性病例对照研究
Cureus. 2022 Jun 23;14(6):e26230. doi: 10.7759/cureus.26230. eCollection 2022 Jun.
7
Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.原发性抗体缺陷与继发性抗体缺陷：免疫球蛋白替代治疗的临床特征及感染结局
PLoS One. 2014 Jun 27;9(6):e100324. doi: 10.1371/journal.pone.0100324. eCollection 2014.
8
Organising pneumonia due to dronedarone.决奈达隆所致机化性肺炎
J R Coll Physicians Edinb. 2015;45(3):213-4. doi: 10.4997/JRCPE.2015.308.
9
A Case of Chronic Pulmonary Aspergillosis due to Pulmonary Infarction, Mimicking Cryptogenic Organising Pneumonia.一例因肺梗死导致的慢性肺曲霉病，酷似隐源性机化性肺炎。
Eur J Case Rep Intern Med. 2024 Apr 22;11(6):004501. doi: 10.12890/2024_004501. eCollection 2024.
10
Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.原发性和继发性抗体缺陷症的免疫球蛋白替代治疗：正确的临床方法。
Int Immunopharmacol. 2017 Nov;52:136-142. doi: 10.1016/j.intimp.2017.09.005. Epub 2017 Oct 12.
本文引用的文献
1
Secondary organizing pneumonia associated with protracted COVID: A case series.继发于持续性 COVID 的机化性肺炎：病例系列。
Infect Dis Now. 2024 Apr;54(3):104888. doi: 10.1016/j.idnow.2024.104888. Epub 2024 Mar 15.
2
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.奥密克戎时代新冠病毒病对免疫功能低下人群的影响：基于观察性人群的INFORM研究的见解
Lancet Reg Health Eur. 2023 Oct 13;35:100747. doi: 10.1016/j.lanepe.2023.100747. eCollection 2023 Dec.
3
Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.商业免疫球蛋白产品含有针对严重急性呼吸综合征冠状病毒 2 刺突蛋白的中和抗体。
Clin Infect Dis. 2023 Oct 5;77(7):950-960. doi: 10.1093/cid/ciad368.
4
5
Clinical and radiological outcomes of SARS-CoV-2 related organising pneumonia in COVID-19 survivors.COVID-19 幸存者中与 SARS-CoV-2 相关的机化性肺炎的临床和影像学结果。
Med J Malaysia. 2023 Mar;78(2):131-138.
6
SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.SARS-CoV-2 中和在恢复期血浆和商业的血浆衍生免疫球蛋白产品中。
BioDrugs. 2022 Jan;36(1):41-53. doi: 10.1007/s40259-021-00511-9. Epub 2021 Nov 29.
7
A Case Report of Steroid-Resistant Cryptogenic Organizing Pneumonia Managed with Intravenous Immunoglobulins.静脉注射免疫球蛋白治疗类固醇抵抗性隐源性机化性肺炎的病例报告
Case Rep Pulmonol. 2021 Nov 15;2021:9343491. doi: 10.1155/2021/9343491. eCollection 2021.
8
Antibody Deficiency, Chronic Lung Disease, and Comorbid Conditions: A Case-Based Approach.抗体缺陷、慢性肺部疾病及合并症：基于病例的方法。
J Allergy Clin Immunol Pract. 2021 Nov;9(11):3899-3908. doi: 10.1016/j.jaip.2021.09.031. Epub 2021 Sep 28.
Zotero 插件